Understanding microRNA: The Nobel-Winning Discovery of 2024
In 2024, Victor Ambros and Gary Ruvkun won the Nobel Prize in Medicine for discovering microRNA, genetic switches regulating genes. MicroRNA adds complexity to gene regulation and may lead to medical breakthroughs, especially in cancer and antiviral treatments. Understanding microRNA could also reveal insights into human evolution and disease diagnostics.
The Nobel Prize in Medicine for 2024 was awarded to American scientists Victor Ambros and Gary Ruvkun for their groundbreaking discovery of microRNA, a new type of genetic switch.
Although revealed decades ago, it initially received little attention as a finding of peculiar interest related to worms.
MicroRNA differs from other RNA forms as it acts as a regulatory switch to turn genes on and off, adding complexity to gene regulation.
Their work showed that more than a thousand genes in humans respond to microRNA, and it is present throughout the animal kingdom.
MicroRNAs hold promise for new medical treatments, particularly in cancer and antiviral therapies, though no treatments have yet reached the public.
Researchers are optimistic that microRNA can be pivotal in advancements such as cancer biomarkers and evolutionary studies.
Although revealed decades ago, it initially received little attention as a finding of peculiar interest related to worms.
MicroRNA differs from other RNA forms as it acts as a regulatory switch to turn genes on and off, adding complexity to gene regulation.
Their work showed that more than a thousand genes in humans respond to microRNA, and it is present throughout the animal kingdom.
MicroRNAs hold promise for new medical treatments, particularly in cancer and antiviral therapies, though no treatments have yet reached the public.
Researchers are optimistic that microRNA can be pivotal in advancements such as cancer biomarkers and evolutionary studies.
